Physician profile
Michael R Young
NPI 1578552675
$1,767.84
in general payments reported to CMS, 2019-2025
18 companies · $48.12 in 2025
The $48.12 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.99 · 2020: $45.91 · 2021: $1,500 · 2022: $37.67 · 2023: $62.77 · 2024: $56.05 · 2025: $48.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,200.00 | 2021 | |
| Abbvie INC. | $71.04 | 2021-2024 | |
| Eisai INC. | $69.26 | 2021 | |
| Amgen INC. | $68.42 | 2020-2024 | Repatha, Otezla, Prolia |
| Lilly USA, LLC | $52.77 | 2021-2024 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.32 | 2021 | |
| Pfizer INC. | $39.83 | 2021-2025 | |
| Novo Nordisk INC | $37.72 | 2019-2021 | |
| Astellas Pharma US INC | $32.50 | 2025 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $24.43 | 2022 | |
| Daiichi Sankyo INC. | $21.52 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.23 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $17.03 | 2023 | |
| Nobel Biocare USA | $16.66 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.90 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.95 | 2021 | |
| Sanofi Pasteur INC. | $13.24 | 2022 | |
| Allergan, INC. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.